- Home
- CLRO vs INAB Comparison
CLRO vs INAB Comparison
Compare CLRO & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRO
- INAB
- Stock Information
- Founded
- CLRO 1983
- INAB 2016
- Country
- CLRO United States
- INAB United States
- Employees
- CLRO N/A
- INAB N/A
- Industry
- CLRO Radio And Television Broadcasting And Communications Equipment
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- CLRO Technology
- INAB Health Care
- Exchange
- CLRO Nasdaq
- INAB Nasdaq
- Market Cap
- CLRO 10.3M
- INAB 10.6M
- IPO Year
- CLRO N/A
- INAB 2021
- Fundamental
- Price
- CLRO $5.00
- INAB $2.08
- Analyst Decision
- CLRO
- INAB Strong Buy
- Analyst Count
- CLRO 0
- INAB 2
- Target Price
- CLRO N/A
- INAB $108.00
- AVG Volume (30 Days)
- CLRO 28.7K
- INAB 83.1K
- Earning Date
- CLRO 11-14-2025
- INAB 11-11-2025
- Dividend Yield
- CLRO N/A
- INAB N/A
- EPS Growth
- CLRO N/A
- INAB N/A
- EPS
- CLRO N/A
- INAB N/A
- Revenue
- CLRO $9,689,000.00
- INAB N/A
- Revenue This Year
- CLRO N/A
- INAB N/A
- Revenue Next Year
- CLRO N/A
- INAB N/A
- P/E Ratio
- CLRO N/A
- INAB N/A
- Revenue Growth
- CLRO N/A
- INAB N/A
- 52 Week Low
- CLRO $3.83
- INAB $1.91
- 52 Week High
- CLRO $21.00
- INAB $16.70
- Technical
- Relative Strength Index (RSI)
- CLRO 41.59
- INAB 41.92
- Support Level
- CLRO $5.61
- INAB $2.09
- Resistance Level
- CLRO $5.96
- INAB $2.28
- Average True Range (ATR)
- CLRO 0.40
- INAB 0.17
- MACD
- CLRO -0.09
- INAB -0.02
- Stochastic Oscillator
- CLRO 0.53
- INAB 4.92
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.